Revvity, Inc. RVTY
$143.45
-2.24%
at last close
Market Cap$16.01 billion
P/E Ratio—
Div Yield0.20%
Volume3.32M
52-Week Range
$81.22$149.52
Analyst Ratings
- Consensus
- Hold — 4 Buy · 11 Hold · 0 Sell (15 analysts)
- Avg. Price Target
- $117.77 (-17.9% downside)
Key Stats
- Today's Range
- $142.45 – $146.88
- 50-Day Range
- $102.36 – $149.52
- 52-Week Range
- $81.22 – $149.52
- Volume
- 3.32 million shs
- Average Volume
- 1.76 million shs
- Market Cap
- $16.01 billion
- P/E Ratio
- —
- Dividend Yield
- 0.20%
Dividend
- Dividend Yield
- 0.20%
- Annual Dividend
- $0.28
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-10-23
Short Interest
- Short Interest
- 2.98%
- Days to Cover
- 4.01
About Revvity, Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Related Stocks
Compare head-to-head: RVTY vs WAT·RVTY vs BIO·RVTY vs TXG·RVTY vs BRKR
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.